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Abstract
Objectives: To determine similarities and differences in the reasons for using or not using complementary and
alternative medicine (CAM) amongst general and condition-specific populations, and amongst populations in each
region of the globe.
Methods: A literature search was performed on Pubmed, ScienceDirect and EMBASE. Keywords: ‘herbal medicine’
OR ‘herbal and dietary supplement’ OR ‘complementary and alternative medicine’ AND ‘reason’ OR ‘attitude’.
Quantitative or qualitative original articles in English, published between 2003 and 2018 were reviewed. Conference
proceedings, pilot studies, protocols, letters, and reviews were excluded. Papers were appraised using valid tools
and a ‘risk of bias’ assessment was also performed. Thematic analysis was conducted. Reasons were coded in each
paper, then codes were grouped into categories. If several categories reported similar reasons, these were
combined into a theme. Themes were then analysed using χ2 tests to identify the main factors related to reasons
for CAM usage.
Results: 231 publications were included. Reasons for CAM use amongst general and condition-specific populations
were similar. The top three reasons for CAM use were: (1) having an expectation of benefits of CAM (84% of
publications), (2) dissatisfaction with conventional medicine (37%) and (3) the perceived safety of CAM (37%).
Internal health locus of control as an influencing factor was more likely to be reported in Western populations,
whereas the social networks was a common factor amongst Asian populations (p < 0.05). Affordability, easy access
to CAM and tradition were significant factors amongst African populations (p < 0.05). Negative attitudes towards
CAM and satisfaction with conventional medicine (CM) were the main reasons for non-use (p < 0.05).
Conclusions: Dissatisfaction with CM and positive attitudes toward CAM, motivate people to use CAM. In contrast,
satisfaction with CM and negative attitudes towards CAM are the main reasons for non-use.
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Background
Use of complementary and alternative medicine (CAM)
has become widespread in the last two decades. The
prevalence of CAM use in general populations world-
wide ranges from 9.8% to 76% [1]. Twelve systematic re-
views report reasons for CAM use mainly in cancer
populations compared to other condition-specific popu-
lations [2–5].
Five of the systematic reviews aimed to determine rea-
sons for CAM use in either general or condition-specific
populations [2, 5–8]. The reviews reported that the main
reasons for CAM use were: (a) expected benefits and
perceived safety of CAM, (b) control and participation
in their therapy, and (c) alignment of socioculture, be-
liefs and needs. The other six reviews also reported rea-
sons for CAM use, but this issue was not their main aim
[3, 4, 9–12]. Their findings showed various reasons for
CAM use, such as: (1) the benefits and safety of CAM,
(2) availability and accessibility of CAM, (3) influence
from friends, family, and the mass media, and (4) dissat-
isfaction with conventional medicine (CM). One system-
atic review from sub-Saharan Africa also reported
barriers to CAM use that included: (a) the absence of
conclusive scientific evidence for CAM, (b) a lack of be-
lief in safety and efficacy of CAM, and (c) unhygienic
practice in product preparation [9].
A narrative review (Jones et al., 2019) aimed to deter-
mine factors influencing CAM use in Australia and re-
ported that cancer and other condition-specific
populations shared some reasons for CAM use: (a) self-
perceived ill health, (b) sense of well-being and (c) inte-
grative treatment [13].
However these reviews do not directly compare simi-
larities and differences in the reasons for CAM use be-
tween populations. There are also limited systematic
reviews reporting reasons for not using CAM. The
present review aimed to provide comprehensive under-
standing of factors influencing different populations to
use/not use CAM.
Methods
The Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) 2009 statement was
employed in the present systematic review [14]. Research
questions of this review were 1) What were the similar-
ities and differences in reasons for using/not using CAM
amongst general and condition specific populations? and
2) What were the similarities and differences in reasons
for using/not using CAM amongst populations in each
region?
Search strategy
The databases – PubMed: National Library of Medicine,
ScienceDirect and EMBASE were searched. It is
recommended that two or more databases are searched.
EMBASE alone has the highest percentage recall of pa-
pers and, as a result, gains in searching resources beyond
EMBASE are modest [15–17]. Keywords used were
‘herbal medicine’ OR, ‘herbal and dietary supplement’
OR, ‘complementary and alternative medicine’, AND
‘reason’ OR ‘attitude’. Free-text terms combined with
Boolean operators and filters were used for searching
relevant studies [18]. For example, ‘complementary and
alternative medicine’ AND ‘reason’; ‘complementary and
alternative medicine’ AND ‘attitude’. All permutations of
these key words were performed. Herbal medicine and
dietary supplements were used as keywords due to these
products being extensively used worldwide, compared to
other types of CAM [19–25]. Pubmed and EMBASE
were chose because they are the main sources suggested
by the Cochrane centre and provide relevant studies in
this field [26]. Meanwhile, the ScienceDirect database
has published information relating to the social sciences
A date range of January 2003 to December 2018 was set
as the World Health Organization’s (WHO) 2002 defin-
ition of CAM was used to underpin this research: “CAM
are used to refer to a broad set of health care practices
that are not part of a country’s own tradition, or not in-
tegrated into its dominant health care system” [27]. This
current review began in 2019 and has reviewed relevant
sources published ovevr a 15 year period from 2003 to
2018.
Selection criteria
Original articles published in English from 2003 to 2018
were reviewed. Quantitative, and qualitative studies, and
mixed-methods research were included as each type of
publication provided a different informational perspec-
tive and complemented each other. No limits were set
regarding country of origin or type of population. This
process was conducted by two independent reviewers.
Exclusion criteria
Conference proceedings, pilot studies, study protocols,
letters, literature reviews or systematic reviews were ex-
cluded. The studies which did not report on factors or
reasons for using, or not using, CAM were excluded.
Furthermore, papers which studied some specific groups
were also excluded, i.e. students, medical professionals,
pregnant women, people aged less than 15 years, care
givers, or specific sexual identities or ethnic groups. This
exclusion was due to the premise that each group has a
specific characteristic which may underpin their reasons
for CAM usage, which may deviate from other popula-
tions. As the present review focused on the reasons and
attitudes influencing people to use/not use CAM, effi-
cacy trials of CAM were also excluded.
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Data extraction and risk of bias assessment
The process of extracting data from publications was
conducted by two independent reviewers. Any disagree-
ments were resolved by discussion with a third reviewer.
The included quantitative studies were appraised using a
standard tool adapted from Gan’s study, which con-
tained 10 items and assessed a study’s internal and ex-
ternal validity [22]. Meanwhile, the qualitative studies
were assessed by a standard tool from Jakes’ study,
which evaluated agreement between research questions,
methods, representation, interpretation of results, influ-
ence of researchers, evidence of ethical approve and a
flow from the analysis to conclusion [12]. These tools
have been used for evaluating studies in the CAM field
and seem to be appropriate to assessing the methodolo-
gies of the observational and qualitative studies included
in this present systematic review.
Data synthesis and statistical analysis
Data in the present systematic review was analysed by
both qualitative and quantitative methods conducted by
two independent reviewers [28]. An inductive thematic
approach was performed to identify themes of reasons
for use and non-use of CAM [28]. All use or non-use
reasons in each publication were coded by hand, and
then grouped into a category according to the reason(s).
If several categories reported similar reasons, such cat-
egories were combined into one theme. The themes,
therefore, emerged from this process. This process was
forward and backward analysed until the themes were
consistent. Then, similarities and differences of the
themes between general and condition-specific popula-
tions, and between Western and Asia populations were
analysed by χ2-tests. Tests were two-tailed and a p-value
< 0.05 was considered statistically significant.
Results
Searching via the three databases provided 10,887 publi-
cations. After excluding irrelevant publications based on
their title and abstract, 2,007 publications remained,
from which 861 duplicates were removed. 799 publica-
tions met the exclusion criteria and were therefore not
included. From the 347 full-text articles reviewed, 116
publications were excluded due to an absence of report-
ing factors or reasons for CAM use, resulting in 231
Fig. 1 Flowchart of study identification process
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publications from 51 countries being included in the
analysis (Fig. 1).
Thirty-seven out of the 231 included publications were
qualitative studies (16%) mainly from the United King-
dom (UK) [29–34], the United States (US) [35–38],
Australia [39–41] or Canada [42–44]; a survey or cross-
sectional study were the most commonly employed
quantitative methods in the included publications
(80.5%). Only eight mixed method papers (3.5%) re-
ported the reasons for CAM use [32, 45–51]. Eleven
papers (4.8%) were conducted in elderly populations
[35, 39, 42, 43, 52–58], and six (2.6%) in women only
populations [29, 38, 39, 59–61].
The highest number of all included publications origi-
nated in Asia (25.5%), followed by Europe (20.9%), North
America (20.0%) and the Middle East (14.7%). A small
number of publications from Australia were also in-
cluded in the present systematic review (7.8%).
To gather information the majority of the quantitative
papers utilised questionnaires which provided a list of
factors or reasons for using CAM based on previous
studies. The majority of the included qualitative studies
utilised interviews or focus groups with open-ended
questions and employed thematic or inductive analyses.
Sixty-four percent of the included publications defined
CAM based on the National Center for Complementary
and Alternative Medicine (NCCAM), the World Health
Organization (WHO, 7%), and the others, e.g. the Food
and Drug Administration, the Dietary Supplement and
Health Education Act (DSHEA), Ernst’s definition,
Eisenberg’s definition, etc.
Figure 2 shows an increase in the number of publica-
tions related to reasons for CAM use amongst
condition-specific populations since 2013, compared
with publications involving general populations. The
total number of publications dealing with CAM use
amongst general and condition-specific populations in
this review was 48 (21%) and 179 (77%), respectively.
The number of the papers in condition-specific popula-
tions is higher than in general populations (Fig. 2), i.e.
cancer (29.0% of publications), diabetes (5.6% of publica-
tions), cardiovascular disease and hypertension (5.2% of
publications), human immunodeficiency virus (HIV)
(3.5% of publications), inflammatory bowel disease (3%
of publications), pain (3% of publications), chronic kid-
ney disease (2.6% of publications), and depression (0.9%
of publications). The majority of studies in the present
review reported various types of CAM use (69%),
followed by herbal medicine (18%) and traditional medi-
cine, including traditional Chinese medicine (1%).
The risk of bias assessment resulted in one quantita-
tive publication being excluded due to poor internal and
external validity. The included studies addressing general
populations had a low bias risk (mode of a total score =
10, range 7-10), and for condition-specific populations
there was a moderate risk of bias (mode of a total score
= 7, range 5 – 10). The weaknesses of studies involving
condition-specific populations was mainly due to a lack
of reporting of their randomisation procedure (73% of
the publications), how representative the sample was
(64%), and non-response bias (48%). Details of the risk
of bias assessment provided in a supplementary material
no. 1.
Lack of reporting the researcher’s background (69% of
the publications) and the influence of reseachers on the
research (60%) were the main weaknesses of the
Fig. 2 Trend in numbers of the publications of reasons for CAM use
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included qualitative studies in both general and
condition-specific populations.
Themes of reasons for use and non-use of CAM
Both quantitative and qualitative studies reported similar
reasons for CAM use. Thirty-three (14.3%) publications
provided reasons for use as well as non-use of CAM.
The present systematic review found three main factors
related to reasons for CAM use: positive attitudes to-
ward CAM, negative attitudes toward CM, and other
factors, i.e. influence of their social network, their doc-
tor’s recommendation, having an internal health locus of
control and tradition (Fig. 3). Reasons for non-use of
CAM were having negative attitudes toward CAM and
positive attitudes toward CM.
Reasons for CAM use amongst general and condition-
specific populations
There was no difference in reasons for CAM use be-
tween general and condition-specific populations. The
top three reported reasons for CAM use in all popula-
tions were perceived benefits (84% of publications), and
safety of CAM (37%), and dissatisfaction with CM (37%).
The most reported expected benefits of CAM were
treatment of illnesses, alleviation of symptoms, reducing
side effects of CM, maintenance of well-being, or pre-
vention of disease. People also reported that using CAM
was a last resort [29, 44, 52, 62–64]. Improving physical
and emotional well-being, and quality of life were further
reasons for using CAM in patients with cancer [50, 63,
65–72]. The cancer patients also reported using CAM to
reduce side effects of CM [33, 45, 65, 66, 69, 73–80].
Western populations in both the general and condition-
specific populations were more likely to report combin-
ing CAM and CM helped them [33, 54, 74, 81–84]. Like-
wise, condition-specific populations in some Asian and
Middle East countries perceived that CAM complemen-
ted CM [63, 85–89]. Even though CAM is more likely to
be a mainstream therapy in Asian countries, the Asian
condition-specific populations tend not use CAM as a
substitute for CM. However, CM is substituted with
CAM amongst general populations in Japan [90].
Regarding dissatisfaction with CM, being ineffective
and/or causing side effects were the most frequently re-
ported reasons in both general and condition-specific
populations for their lack of satisfaction [29, 36, 40, 54,
81, 87, 91–107]. Some patients wanted to use CAM in
order to either avoid side effects resulting from CM or
to decrease the number of conventional medicines taken
[49, 92, 103, 108–112]. A lack of trust in CM as the rea-
son for using CAM was reported in three publications
from Asia, two from the Middle East and one from Eur-
ope [61, 94, 113–116]. Additionally, condition-specific
populations decided to use CAM to avoid invasive care
or aggressive treatment [80, 111]; or they were disap-
pointed with or had negative experience of conventional
care and/or the staff providing it [41, 80, 86, 97, 103,
105, 117–119]. CAM users in both Asian and Western
populations preferred to visit CAM practitioners because
Fig. 3 Factors related to reasons for CAM use and non-use
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they provided fuller explanations and more time when
compared with conventional health professionals [34, 66,
86]. Condition-specific populations in Asia and Africa often
found it difficult to access CM; a circumstance which drove
them to use CAM [97, 120].
Only 8.7% of publications found that condition-
specific populations viewed CAM as natural, and thus
safe [21, 29, 49, 65, 67, 76, 92, 100, 106, 107, 112, 114,
121–129]. Six studies from Europe, Asia and Africa also
reported ‘being curious’ as the reason for using CAM
[92, 97, 130–133].
Other factors were influenced by CAM users’ social
networks (27% of publications), having an internal health
locus of control defined as preferring to control or de-
cide choices of health treatments themselves (28%), af-
fordability of CAM (24%), willingness to try or use CAM
(including hope) (21%), conventional health profes-
sionals’ recommendation (18%), easy access to CAM
(14%), belief in a holistic approach (12%), and tradition/
belief (12%). Internal health locus of control and a holis-
tic approach were more likely to reported by Western
populations, as such reasons may be developed from or
informed by a Western perspective [30, 31, 34, 37, 42,
45, 46, 48, 50, 55, 56, 67, 68, 71, 73, 80, 91, 93, 95, 106,
107, 125–128, 130, 134–159].
Similarities and differences in reasons for CAM use
amongst patients with cancer and other chronic illnesses
The literature shows that patients with various illnesses
share the main reasons for CAM use, such as perceived
benefits of CAM use or dissatisfaction with CM rather
than having different reasons in specific diseases [36, 40,
41, 48, 57, 62, 84, 86, 87, 92, 96, 99, 104, 108, 125, 160–
167]. However, being influenced by social media, having
an internal health locus of control, or willingness to try
CAM were reported more frequently by cancer patients
than other members of condition-specific populations
(Fig. 4). Meanwhile dissatisfaction with CM, affordability
of CAM and easy access to CAM were more frequently
reported by patients with other chronic illnesses (p <
0.05). Patients with cancer, whilst accepting the efficacy
and safety of CM, may use CAM in order to comple-
ment the efficacy of chemotherapy and/or reduce its un-
pleasant side effects (36% of publications in cancer
populations) [33, 34, 45, 63–67, 69, 71, 73–79, 88, 122–
124, 139, 152].
Reasons for CAM use in each region
There was no global difference in the reported reasons
for using CAM, namely the benefits of CAM, dissatisfac-
tion with CM, and safety of CAM, see Fig. 5. However,
the number of publications in Europe (35% of publica-
tion), North America (48%) and South America (75%)
that reported dissatisfaction with CM as the reason for
using CAM was higher than in other populations. The
benefits (89% of publications) and safety of CAM (50%)
were reported as of the main reasons for CAM use in
Australian populations.
An internal health locus control, affordability and easy
access of CAM, as well as tradition/belief were signifi-
cantly different in each region (p < 0.05). Internal health
locus control influenced people in Australia (50% of
publications), South America (50%), and Europe (48%).
Additionally, tradition significantly influenced CAM use
in South America (38% of publications), Africa (28%)
and Asia (17%), compared with other regions. A high
Fig. 4 Comparing the reasons for CAM use amongst cancer patients and patients with other chronic illnesses. * Statistical significant at p < 0.05
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proportion of publications in Asian (37%) and Australian
populations (33%) reported that social networks influ-
enced them to use CAM, compared with other regions.
African populations had the highest proportion of re-
ported affordability of CAM (67%) and easy access (56%)
as reasons for CAM use, whilst no report of these rea-
sons was found in European populations. European pop-
ulations (23% of publications) are more likely to report
conventional health professionals’ recommendations for
CAM use as their reason, compared with other regions.
Regarding reasons for CAM use amongst Western and
Asian populations, Asian populations more frequently
reported using CAM due to being influenced by mem-
bers of their social network, low costs of CAM, easier
access to CAM and tradition than Western populations
(p < 0.05), Fig. 6. Meanwhile, having an internal health
locus of control is the main reason for CAM use in
Western populations (p < 0.05).
Reasons for non-use amongst Western and Asian
populations
The studies of reasons for non-use are limited compared
to the reasons for using CAM, so comparison of the
reasons for non-use in each region cannot be made. No
publications from the Middle East or South America
were included in the present systematic review. Two
publications from Africa and Australia were included.
The majority of studies in the included publications were
conducted in Asia, Europe or North America. Therefore,
we compared Asian and Western populations.
Thirty papers in condition-specific populations [45, 47, 65,
75, 79, 80, 95, 107, 115, 120, 123, 124, 130, 150, 152, 157,
162, 168–179], six in general populations [180–185], one
publication involving elderly people [53] and one publication
involving females [61] reported the reasons for not using
CAM. Asian populations more frequently reported doubt
about the efficacy of CAM or lower effectiveness of CAM
compared to CM, concerns about side effects of CAM, and
inconvenience or unavailability of CAM than did members
of Western populations (p < 0.05), Fig. 7 [47, 75, 79, 120,
170, 172, 174–177, 179–181]. Some publications in Asian
populations also reported concern about CAM reducing the
efficacy of CM as a reason for non-use [169, 170].
Meanwhile, Western populations mainly reported sat-
isfaction with CM (45% of publications, p < 0.05) or had
never considered using CAM (60%, p < 0.05) [45, 65, 95,
Fig. 5 Comparison of the reasons for CAM use worldwide. * Statistical significant at p < 0.05
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123, 124, 130, 150, 152, 157, 162, 171, 182, 184, 186].
Other reasons for the non-use of CAM were lack of reli-
able information about the efficacy of CAM, the high
cost of CAM, and it not being recommended by conven-
tional health professionals or the ‘patient’s’ family.
Discussion
The included studies in the present systematic review
can be seen to represent CAM use worldwide as they
were mainly from Asia, Europe, North America, Middle
East, and Australia. Recently, researchers in Asia have
Fig. 7 Reasons for non-use between Asian and Western populations. * Statistical significant at p < 0.05
Fig. 6 Comparison of the reasons for CAM use between Asian and Western populations. * Statistical significant at p < 0.05
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become interested in this field as several CAMs are em-
bedded in their culture and society. Publications from
this region has been rising since 2008; however, readers
should be aware that the present systematic review in-
cluded a small number of eligible publications from
Australia and South America. Although a high number
of publications originated in Australia, they tended to
study specific populations, e.g. middle-aged women, and
other topics, rather than reasons for CAM use. Re-
searchers may less likely to investigate reasons for CAM
use in South America, compared to other regions.
Therefore, the findings in the present systematic review
may be less likely to be generalisable in Australian and
South American populations.
The present systematic review included a high number
of publications amongst cancer, diabetic, cardiovascular
disease, and HIV populations. It would therefore seem
that illnesses, such as these which cannot be satisfactor-
ily treated by CM, or when CM has significant unpleas-
ant side-effects, drive some patients to seek CAM.
Cancer populations have been studied regarding reasons
for CAM use more than other condition-specific popula-
tions. There are six systematic reviews of the reasons for
CAM use in patients with cancer [2, 3, 5, 8, 187, 188].
As expected, three main factors related to reasons for
CAM use in the present systematic review were positive
attitudes toward CAM, negative attitudes toward CM and
other factors, i.e. the influence of their social network,
their doctor’s recommendation, having an internal health
locus of control and tradition. The top three reported rea-
sons for CAM use were perceived benefits and safety of
CAM, and dissatisfaction with CM. These findings are
consistent with previous systematic reviews [3, 9–12].
These reasons are similar in both general and condition-
specific populations, and in populations from different
global regions, as cited frequently above. Although the
present systematic review included a limited number of
publications from Australia, benefits and safety of CAM
were reported as the main reasons for CAM use in Aus-
tralian populations. These findings agree with a previous
systematic review in Australia [6].
Despite limited scientific evidence for the benefits of
CAM [189], the ‘expected benefits’ of CAM was the
most frequently reported reason for CAM use. This
finding is not surprising as people tend to seek CAM as
a way of meeting their needs or filling a gap left by con-
ventional medicine. The included publications amongst
the cancer population are more likely to report CAM
use for reducing the negative and often unpleasant side
effects of CM. This finding is consistent with systematic
reviews of CAM users with prostate or advanced cancer
[3, 4]. Additionally, the cancer population seems to
accept the efficacy and side effects of CM, and therefore
uses CAM to complement CM.
Previously, people believed that CAM is natural and
safe [190]. This idea may have led many patients with
chronic illnesses on using CAM instead of CM. How-
ever, the present systematic review indicates that a small
number of the included publications amongst condition-
specific populations reported that CAM is safe as a rea-
son for CAM use. Therefore, CAM as natural therapy is
not the main reason for CAM use; a point which may be
linked to the high number of reported adverse events
from using CAM [191–193]. Patients therefore should
use CAM with caution or under supervision from con-
ventional or CAM practitioners.
Regarding other factors related to CAM use in each
region, nearly half of the included publications reported
that internal health locus control influenced people in
Australia, South America, and Europe. However, this
reason may have been reported less by Asian, Middle
Eastern and African people, as they may not explain
their reasons in such terms. Tradition also significantly
influenced CAM use in South America, Africa and Asia,
compared with other global regions. This orientation
may be because CAM, for example, herbal medicine, is
embedded in such regions and therefore aligns with their
populations’ socio-culture values. Social networks influ-
enced Asian and Australian populations to use CAM,
compared with other regions, as they may have a close-
knot family or community structure.
Affordability of CAM, together with easy access, are
likely to be the main reasons for CAM use amongst Af-
rican populations. The high cost of, and poor accessibil-
ity to, CM appears to influence people to use CAM in
Africa [57, 58, 97, 164, 183, 194–201]. Meanwhile, no re-
port of these reasons was found in European popula-
tions. CAM may not be cheap and easy to access in
Europe, compared with CM as users have to personally
pay for CAM and it can be difficult to access [19]. More-
over, European populations are more likely to report
conventional health professionals’ recommendations for
CAM use as their reason for choosing that option, com-
pared with other global regions. This option may be be-
cause health care is readily available in most European
countries; so when they have a health problem, they visit
their general practitioner.
There are limited publications reporting reasons for
non-use of CAM in each region. Further studies relating
to this issue are required, particularly in populations
from Africa, the Middle East and South America. The
present systematic review found that Asian populations
are more likely to question the efficacy and safety of
CAM, and to be concerned about potentially harmful in-
teractions between herbal medicines and CM. These
findings imply that Asian populations seem to under-
stand the limitations of CAM, the efficacy and safety of
CAM, and are aware of herb-drug interactions.
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The findings confirm that Western populations do not
use CAM if they are satisfied with the efficacy and safety
of CM. This outcome may be because they can easily ac-
cess CM, and CAM is less likely to be considered as an
option for chronic illnesses in Western countries. How-
ever, if they were to become disappointed with the CM/
staff, they may decide to use CAM. This possibility is
consistent with the systematic review of patients with
cancer, which reported that the patients who were satis-
fied with CM did not use CAM [3]. Lack of reliable in-
formation about the efficacy of CAM, as a barrier to
CAM use reported in the present systematic review, is
consistent with the findings from a previous systematic
review [9].
Limitations of this review
Although this review only selected a small number of
key words, and only three search engines in order to
search the literature the findings returned 43% duplicate
publications. Further reviews should search using a wide
range of CAM types as keywords, e.g. yoga, acupuncture,
relaxation, etc., in order to confirm the findings from
the present review. There was a small number of publi-
cations addressing the reasons for CAM use in South
America (n = 8); thus the findings from that continent
should be interpreted with caution. This review included
only publications in English; as a result the findings did
not represent publications in other languages. Regarding
the results from the search strategy used in this review,
only 5% of the papers were excluded due to being non-
English. This outcome is unlikely to have any significant
impact on the findings of the present review, as most of
the studies were conducted in Europe, from where a
high number of publications in English were identified
for inclusion in this review.
Results of publications in condition-specific popula-
tions representing a national population should also be
interpreted with caution due to only 36% of these studies
being designed to represent the patient population. The
present systematic review found poor external validity of
the included studies amongst condition-specific popula-
tions, therefore future studies should be aware of this
issue.
Impact of the findings for conventional health
professionals
Expected benefits of CAM are the main reason for CAM
use despite a lack of clinical trials. To promote the ra-
tional use of CAM, health care providers should be
ready to provide such information to their patients and
conventional medicine guidelines should report reliable
information about CAM, and be easily available to,
health care providers. The findings in the present review
have confirmed that being disappointed with CM or
associated professional providers, particularly in Western
populations, is more likely to influence condition-
specific populations to use CAM. To prevent patients
from using CAM inappropriately, health care providers
should spend more time clearly explaining treatment op-
tions, the likely treatment outcomes and potential nega-
tive effects of CAM, including herb-drug interactions.
Having an internal health locus of control seems to be
a main reason for CAM use in Western populations.
This finding implies that patients prefer deciding a ther-
apy by and for themselves. To decrease inappropriate
use of CAM, conventional health care providers should
offer sufficient health information to their patients, as
well as holding a discussion with a patient, before decid-
ing upon a health therapy.
A person’s social network is more likely to influence
their decision making regarding CAM in Asian popula-
tions. Therefore, health care providers should educate
not only patients about how to properly use CAM, but
also their friends and family members.
Conclusions
It is clear that the main reasons for CAM use in all pop-
ulations are a positive attitude toward CAM, that is the
perceived benefit and safety of CAM, and a negative atti-
tude toward CM, a dissatisfaction with CM. Having an
internal health locus of control is a more frequently re-
ported reason for CAM use in Western populations,
whilst being influenced by social networks is a common
reason for its adoption amongst Asian populations. Af-
fordability, easy access to CAM and tradition are the
most common reasons amongst African populations.
Negative attitudes towards CAM and satisfaction with
CM are more likely to be the reason for non-use. Con-
ventional health professionals should acknowledge that
people may turn to CAM in order to serve their needs.
Therefore, health care providers should regularly ask
their patients about their use of CAM before that pro-
viders prescribes any conventional medicines, in order to
prevent undesirable adverse effects or CAM-drug inter-
actions. Further studies are required to investigate rea-
sons for CAM use in South America and reasons for
non-use in all global regions, in order to provide more
conclusive evidence in this field.
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